aTyr Pharma Priced, Nasdaq: LIFE

Developing a new class of protein therapeutics for rare muscular dystrophies.

Industry: Health Care

Latest Trade: $3.65 0.00 (0.0%)

First Day Return: +6.8%

Return from IPO: -73.9%

Industry: Health Care

We engage in the discovery and clinical development of innovative medicines for patients suffering from severe, rare diseases using our knowledge of Physiocrine biology, a newly discovered set of physiological modulators. We have discovered approximately 300 Physiocrines, a class of naturally occurring proteins that we believe promote homeostasis, a fundamental process of restoring stressed or diseased tissue to a healthier state. Physiocrines are extracellular signaling regions of tRNA synthetases, an ancient family of enzymes that catalyze a key step in protein synthesis. We believe that Physiocrines have evolved over time to modulate important cellular pathways by interacting with various types of cells, including immune and stem cells. Approximately 100 of these proteins interact with the immune system, which we believe presents a significant therapeutic opportunity to restore affected tissues to a healthier state through natural immuno-modulation mechanisms. We successfully completed a Phase 1 clinical trial of Resolaris, our first development candidate from our discovery engine, and are currently conducting a multi-national exploratory Phase 1b/2 clinical trial of Resolaris in adult patients with facioscapulohumeral muscular dystrophy, a severe, rare genetic myopathy with an immune component, for which there are currently no approved treatments. By leveraging our discovery engine and our knowledge of rare diseases, we aim to build a proprietary pipeline of novel product candidates with the potential to treat severe, rare diseases characterized by immune dysregulation. We plan to independently commercialize our Physiocrine-based therapeutics.
more less
IPO News for aTyr Pharma
more
IPO Data
IPO File Date 04/06/2015
Offer Price $14.00
Price Range $13.00 - $15.00
Offer Shares (mm) 5.4
Deal Size ($mm) $75
IPO Data
IPO Date 05/06/2015
Offer Price $14.00
Price Range $13.00 - $15.00
Offer Shares (mm) 5.4
Deal Size ($mm) $75
Underwriters
more
Company Data
Headquarters San Diego, CA
Founded 2005
Employees 49
Website www.atyrpharma.com